MENU
IMMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

A.I. Advisor
published Earnings

IMMX is expected to report earnings to rise 5.56% to -18 cents per share on November 06

Immix Biopharma IMMX Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Est.
$-0.18
Q1'26
Beat
by $0.03
Q4'25
Missed
by $0.08
Q3'25
Missed
by $0.08
The last earnings report on August 07 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 819.07K shares outstanding, the current market capitalization sits at 608.80M.